Seer (SEER) Change in Account Payables (2020 - 2026)
Seer (SEER) recorded quarterly Change in Account Payables of -$3.0 million in Q1 2026, down 338.11% quarter-over-quarter from $1.3 million in Q4 2025, and down 27218.18% on a YoY basis from N/an in Q1 2025.
Seer (SEER) Change in Account Payables (2020 - 2026) Analysis & Trends
Seer's Change in Account Payables history runs 7 years deep, the most recent figure standing at -$3.0 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 27218.18% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$1.9 million (down 198.42% YoY), while the FY2025 annual figure was $1.1 million, down 68.35% from the prior year.
- Change in Account Payables was -$3.0 million for Q1 2026 at Seer, down from $1.3 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.7 million in Q4 2024 to a low of -$3.7 million in Q3 2024.
- Historically, Change in Account Payables has averaged -$66352.9 across 5 years, with a median of -$11000.0 in 2025.
- The sharpest annual moves came in 2024 and 2026: Change in Account Payables jumped 203300.0% in 2024, then tumbled 27218.18% in 2026.
- A 5-year view of Change in Account Payables shows it stood at -$1.1 million in 2022, then soared by 132.97% to $366000.0 in 2023, then surged by 906.01% to $3.7 million in 2024, then plunged by 65.73% to $1.3 million in 2025, then slumped by 338.11% to -$3.0 million in 2026.
- The last three Change in Account Payables figures came in at -$3.0 million (Q1 2026), $1.3 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -9.42 Mn |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | -3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.01 Mn |
| Mar 31, 2026 | -3.01 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | -11,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Dec 31, 2024 | 3.68 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | -3.74 Mn |
| Sep 30, 2024 | -3.74 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 366,000.00 |
| Dec 31, 2023 | 366,000.00 |